Skip to main content
Fig. 10 | Cancer Nanotechnology

Fig. 10

From: HB5 aptamer-tagged graphene oxide for co-delivery of doxorubicin and silibinin, and highly effective combination therapy in breast cancer

Fig. 10

Apoptosis rate analysis after SK-BR-3 (A) and MCF-7 (B) cells were exposed to different formulations for 48 h using flow cytometry. The flow cytometric charts indicate early apoptotic cells (Q1), late apoptotic cells (Q2), viable cells (Q3), and necrotic cells (Q4). C Comparative apoptotic rates between SK-BR-3 and MCF-7 cells exposed to different formulations for 48 h. The analyzed values are shown as mean ± SD. (n = 3). ***p < 0.001, ##p < 0.01. cGO: carboxylated graphene oxide; Apt: aptamer; DOX: doxorubicin; Sili: silibinin

Back to article page